Chapter 249 - 200: Times Have Changed, Wu Ting’s Confidence

Chapter 249: Chapter 200: Times Have Changed, Wu Ting’s Confidence

[Note: While the clinical diagnosis of patients with typical hepatic encephalopathy is not difficult, patients with subclinical or covert hepatic encephalopathy, who show no obvious clinical signs and only slight abnormalities in liver biochemical indicators, are prone to misdiagnosis.]

[Acquired Trait from Director Shen Xiaofei: Diagnosis and Treatment Techniques for Acute Liver Failure (Purple). The culmination of Director Shen Xiaofei’s decades of experience. Acute Liver Failure (ALF) involves the rapid onset of severe complications after the first signs of liver disease, indicating that the liver has sustained severe damage. Its complications include hepatic encephalopathy and impaired protein synthesis.]

Looking at these two new traits, Wu Ting felt a surge of pleasant surprise. ’As expected of the top expert in liver surgery at Jinggang University Affiliated First Hospital!’

Fan City First Hospital’s ability to treat hepatic encephalopathy and acute liver failure was relatively weak. Previously, if patients with similar, severe symptoms appeared, they were transferred directly to a higher-level hospital.

Now that Wu Ting had mastered these two top-tier techniques, it was another round of "technological aid" for Director Cai Qi’s hepatobiliary surgery department!

As Wu Ting continued to build his prestige in hepatobiliary surgery, it would also help his plan to later establish an independent Hepatic Tumor Surgery department.

After he returned this time, Wu Ting planned to talk to Director Cai and Dean Tang about his idea of creating a Hepatic Tumor Surgery department.

After all, once his project defense on Friday and the lecture with its star-studded lineup were over, he would hold a pivotal position in the field of hepatic tumors. Although his expertise was limited to the diagnosis and treatment of primary liver cancer related to hepatitis B, he could use that as a specialty. With the recruitment of talent and the accumulation of surgical techniques, his case would be sufficiently persuasive.

Wu Ting had the successful case of the Emergency Department’s Laparoscopic Diagnosis and Treatment Technology Research Center to point to.

Besides, times had changed. Wu Ting’s abilities and status now allowed him to negotiate terms with City First Hospital.

A paper in *Cell*, a paper in *Liver Transplantation*, plus the investment he would bring in himself, and Professor Ye Xin as his backer... Wu Ting couldn’t find any reason for the City First Hospital leadership to refuse him.

In fact, Wu Ting’s willingness to stay at City First Hospital was a stroke of good fortune for the hospital itself!

After successfully completing the surgery, Wu Ting prepared to return to City First Hospital with his team.

Wu Ting needed to prepare for the upcoming "showdown" with Professor Lin Ning at the lecture.

At the same time, he arranged for Cheng Feng to edit the video of this surgery, which would be a major bargaining chip in his negotiations.

Meanwhile, Jinggang University Medical College was also preparing for this grand lecture event, and his own professor had to arrange his project defense.

Therefore, Wu Ting chose to return to City First Hospital to enjoy some peace and quiet.

He went to the ward to check on Liu Xia and give Liu Xingye instructions for her subsequent observation.

Director Ding Han was endlessly grateful for Wu Ting’s help; it was a truly great favor.

He was ready to spare no effort whenever Wu Ting needed him.

...

...

While Wu Ting was back at City First Hospital, settling into his daily work routine, the three major pharmaceutical companies each began to get busy.

Representatives from the three teams checked into hotels near Jinggang University Medical College ahead of schedule.

At the same time, Jin Pharmaceutical Group also began preparations for the lecture.

Deng Feifei had privately sought out Shen Siyuan and learned that Wu Ting was preparing for his project defense and wasn’t seeing anyone. With a sense of propriety, she chose not to disturb him.

As the person in charge of the business negotiations with Wu Ting, Deng Feifei was diligently learning about him while also starting to gather intelligence on the likely bargaining chips the other three top pharmaceutical companies might use.

After some wheedling and pestering, Deng Feifei got a general idea of Wu Ting’s intentions from Shen Siyuan. She decided to take an unconventional approach, different from the plans of the three top pharmaceutical giants, which involved either offering a sky-high price to recruit Wu Ting’s team directly or collaborating with Jinggang University Medical College to establish a lab by pouring in funds, personnel, and equipment.

Deng Feifei planned to support Wu Ting in building his lab back at City First Hospital. She would invest in constructing a new building, new equipment, and funds for recruiting personnel. In return for this collaboration, Deng Feifei would only ask for patent licensing from Wu Ting, or the right of first refusal for collaboration.

Jin Pharmaceutical Group would merely coordinate with Wu Ting’s research, keeping his team at the core of everything. They wouldn’t interfere, let alone try to acquire him for deeper collaboration.

After all, Jin Pharmaceutical Group couldn’t compare to the three top pharmaceutical giants in terms of R&D technology or their reserves of top-tier scientists.

Their only way forward was to provide Wu Ting with funding and equipment support. For the same level of financial support, they hoped to obtain Wu Ting’s verbal promise for the right of first refusal.

Deng Feifei knew very well that Wu Ting was incredibly sought-after right now. If they proposed a collaboration similar to what the three giants would offer, they wouldn’t stand a chance.

Of course, this was also due to the sheer power of the three top pharmaceutical companies. They naturally looked down on Wu Ting with a condescending attitude; their goal was to acquire, take over, buy out, and control.

In fact, for most research teams, facing an acquisition offer or a deep collaboration proposal from top pharmaceutical groups like Pfizer or Johnson & Johnson was their best option.

It was just like when Alibaba acquires promising small companies. They have the strength and confidence; it’s not that they can’t incubate such projects internally, but incubation requires a great deal of time and manpower.

Time is crucial, and R&D is very time-consuming. Therefore, direct acquisition, despite the high cost, allows for a quantifiable return on investment with manageable risks, and the small teams don’t dare to refuse.

Pfizer and the others had this same condescending attitude and approach toward Wu Ting. They didn’t think he would dare refuse; it was just a matter of throwing better terms at him.

Once Deng Feifei had her plan, she quickly put it into action.

Of course, only Deng Feifei and members of the board of directors with the proper clearance knew the core bargaining chips.

Under Deng Feifei’s command, the R&D department of Jin Pharmaceutical Group began working overtime on the preparations.

Chai Ming, as a newcomer to the R&D department, was currently stuck with running errands and doing odd jobs.

This time, he was assigned to create the content related to the R&D department’s strength for Jin Pharmaceutical Group’s presentation PPT.

As a newcomer, he was also scheduled to help out at the conference venue later, which Chai Ming himself was quite happy and excited about.

After all, Chai Ming himself was a bioengineering graduate from Jinggang University, and this event would feature presentations on the corporate cultures of three top pharmaceutical companies in the industry.

Of course, what excited him the most was the final sharing session by Professor Lin Ning.

’That’s Professor Lin Ning, a researcher at the HHMI Research Institute!’

’A tenured professor at the University of Chicago’s Ben May Cancer Research Institute, and also a researcher at the Jin Country Medical Science Academy Basic Hospital Research Institute and the Science Academy...’

Back in his junior year of college, Chai Ming had followed his advisor on a tour of the HHMI Research Institute and had met Professor Lin Ning once.

’I wonder what kind of lecture Professor Lin will give this time.’

Because the organizers were being secretive and deliberately building suspense, Chai Ming was also very curious to see what kind of surprise the mysterious young doctor at the lecture would bring.

Chai Ming remembered that Wu Ting seemed to be a part-time graduate student at Haijin Port Medical College. He wondered if he’d have a chance to attend such a grand event.

But based on the timeline, he was still far from graduating. Otherwise, he could have tried to land a high-paying position at one of the three top pharmaceutical giants.

Speaking of which, at the last class reunion, Chai Ming had been rather surprised that Wu Ting had such impressive connections.

’As expected, having a good mentor and academic lineage is really important.’

At the last reunion, Wu Ting hadn’t wanted to say much, so everyone tactfully refrained from asking further.

However, everyone speculated that Wu Ting had probably ridden on his graduate advisor’s coattails to get to know some top figures in Xiao City’s medical community.

After all, Wu Ting was quite good-looking, so it was normal for him to have some luck with the opposite sex.

Chai Ming, however, had no intention of contacting Wu Ting to ask if he was attending the lecture.

If he ran into him later, he’d say hello. If not, so be it.

After all, at a top-tier gala like this, he and Wu Ting were just small fry watching from a distance, with no real sense of participation or experience.

Besides, anyone with eyes could see that Jin Pharmaceutical Group was just there to make up the numbers. It was rumored that their group was footing the bill for the entire lecture event.

Compared to top companies like Pfizer and Johnson & Johnson, they were truly crushed into the dust.

Still, just being able to participate in a sharing and exchange event with the three top pharmaceutical giants was an honor in itself.

As a newcomer to Jin Pharmaceutical Group, Chai Ming didn’t dare to overthink the company’s objectives for this event. He just had to be a good cog in the machine.

And while he was at it, he could take advantage of his staff access to listen to the presentations by Professor Lin Ning and the mysterious guest speaker in person.